Salute e Benessere
Aidoc and Integral Diagnostics (IDX) Expand AI Partnership in Australia and New Zealand
Aidoc's AI technology has firmly positioned IDX as the market leader in AI-driven medical imaging in Australia and New Zealand , with its aiOS™ platform automatically flagging critical pathologies, including brain aneurysms, pulmonary embolisms, stroke, and brain bleeds.
Since 2019, Aidoc has processed over 600,000 cases across IDX's entire network, including its partner facilities and hospitals. By augmenting radiologists' workflows, it enables prioritization of life-threatening cases when these are detected by the AI, leading to improved care and efficiency, and ultimately facilitating faster, life-saving treatments for patients.
Looking ahead, significant advancements are on the horizon. Starting July 2025 , the Australian Government will fund the National Lung Cancer Screening Programme (NLCSP), a crucial step in early detection of lung cancer. IDX is currently trialling a new algorithm within Aidoc's aiOS™ platform designed to notify radiologists of lung nodules and measure them accurately, enabling earlier and appropriate intervention for lung cancer.
"Aidoc's AI has significantly improved patient care and service. We're keen to test and use their Chest CT AI algorithms to automate our reviews in the National Lung Cancer Screening Programme to enable us to detect disease earlier, more accurately and more efficiently", said Dr. Ian Kadish, CEO and Managing Director at Integral Diagnostics.
Already widely adopted across the United States and Europe , Aidoc's AI aiOS™ platform analyses over 3 million patients monthly and is backed by more than 150 published papers and abstracts. These demonstrate its proven ability to reduce costs, improve patient outcomes and increase efficiency, making it a leader in AI-powered radiology.
This partnership between Aidoc and IDX represents not just a technological leap forward but a shift in how radiology will evolve in the years to come. With AI seamlessly integrated into workflows, healthcare providers can focus on delivering the highest level of patient care. Aidoc and IDX are shaping the future of medical imaging, with early detection, improved patient outcomes and improved healthcare efficiency.
"Our partnership with Integral Diagnostics underscores our commitment to driving better health outcomes," said Rotem Geslevich, Senior Director of Business Development at Aidoc. "As the Lung Cancer Screening initiative approaches, we are excited to play a pivotal role in saving lives."
Both Aidoc and Integral Diagnostics will be featured at the RANZCR conference in Perth from 17-19 October 2024 . Attendees can learn more about the evolving role of AI in radiology and its positive impact on patient care across Australia and New Zealand .
View original content: https://www.prnewswire.co.uk/news-releases/aidoc-and-integral-diagnostics-idx-expand-ai-partnership-in-australia-and-new-zealand-302275816.html